Black Hawk Acquisition Corp

BKHA

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0002000775

SEC filings (opens in a new tab)

No open-market purchases or sales by Black Hawk Acquisition Corp insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $23.3M in total; no superinvestor holds it.

Other share classesBKHAR BKHAU

Superinvestors holding BKHA, Q2 2026

See all superinvestors

No superinvestor reported holding BKHA in Q2 2026.